We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Why Crescent Capital BDC (CCAP) Outpaced the Stock Market Today
Read MoreHide Full Article
The latest trading session saw Crescent Capital BDC (CCAP - Free Report) ending at $15.81, denoting a +1.41% adjustment from its last day's close. The stock outpaced the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.62%, and the tech-heavy Nasdaq gained 0.93%.
The the stock of company has fallen by 10.56% in the past month, lagging the Finance sector's loss of 5.07% and the S&P 500's loss of 2.29%.
Investors will be eagerly watching for the performance of Crescent Capital BDC in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 8, 2023. The company is predicted to post an EPS of $0.56, indicating a 33.33% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $47.12 million, up 62.54% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $2.22 per share and a revenue of $180.75 million, demonstrating changes of +15.03% and +54.86%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Crescent Capital BDC. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Crescent Capital BDC possesses a Zacks Rank of #3 (Hold).
Investors should also note Crescent Capital BDC's current valuation metrics, including its Forward P/E ratio of 7.01. This indicates a premium in contrast to its industry's Forward P/E of 6.84.
The Financial - SBIC & Commercial Industry industry is part of the Finance sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CCAP in the coming trading sessions, be sure to utilize Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Why Crescent Capital BDC (CCAP) Outpaced the Stock Market Today
The latest trading session saw Crescent Capital BDC (CCAP - Free Report) ending at $15.81, denoting a +1.41% adjustment from its last day's close. The stock outpaced the S&P 500's daily gain of 0.73%. At the same time, the Dow added 0.62%, and the tech-heavy Nasdaq gained 0.93%.
The the stock of company has fallen by 10.56% in the past month, lagging the Finance sector's loss of 5.07% and the S&P 500's loss of 2.29%.
Investors will be eagerly watching for the performance of Crescent Capital BDC in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on November 8, 2023. The company is predicted to post an EPS of $0.56, indicating a 33.33% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $47.12 million, up 62.54% from the year-ago period.
For the full year, the Zacks Consensus Estimates project earnings of $2.22 per share and a revenue of $180.75 million, demonstrating changes of +15.03% and +54.86%, respectively, from the preceding year.
Investors should also take note of any recent adjustments to analyst estimates for Crescent Capital BDC. These latest adjustments often mirror the shifting dynamics of short-term business patterns. Therefore, positive revisions in estimates convey analysts' confidence in the company's business performance and profit potential.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To exploit this, we've formed the Zacks Rank, a quantitative model that includes these estimate changes and presents a viable rating system.
The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Over the last 30 days, the Zacks Consensus EPS estimate has witnessed an unchanged state. Right now, Crescent Capital BDC possesses a Zacks Rank of #3 (Hold).
Investors should also note Crescent Capital BDC's current valuation metrics, including its Forward P/E ratio of 7.01. This indicates a premium in contrast to its industry's Forward P/E of 6.84.
The Financial - SBIC & Commercial Industry industry is part of the Finance sector. This group has a Zacks Industry Rank of 85, putting it in the top 34% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
To follow CCAP in the coming trading sessions, be sure to utilize Zacks.com.